Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
2006 1
2011 2
2012 3
2013 3
2014 3
2015 2
2016 2
2017 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
[Clinical use of COX inhibitors--a consensus].
Reikvam A, Hexeberg S, Kvien TK, Slørdal L, Aabakken L, Engebretsen L, Flatø B, Idsø N, Johnsen V, Kalstad S, Madsen S, Mikkelsen K, Os I, REder J. Reikvam A, et al. Among authors: kalstad s. Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):591-5. Tidsskr Nor Laegeforen. 2006. PMID: 16505867 Free article. Review. Norwegian.
A man in his 40s with headache and blurred vision.
Bjørke AB, Wahl CM, Kalstad S. Bjørke AB, et al. Among authors: kalstad s. Tidsskr Nor Laegeforen. 2012 Jun 12;132(11):1353-6. doi: 10.4045/tidsskr.11.0718. Tidsskr Nor Laegeforen. 2012. PMID: 22717862 Free article. English, Norwegian. No abstract available.
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B, Kristianslund EK, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK. Michelsen B, et al. Among authors: kalstad s. Ann Rheum Dis. 2017 Apr;76(4):708-711. doi: 10.1136/annrheumdis-2016-210283. Epub 2016 Oct 4. Ann Rheum Dis. 2017. PMID: 27707730
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.
Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G, Henriksen M, Hoie SS, Krogh J, Midtgard IP, Mielnik P, Moum B, Noraberg G, Poyan A, Prestegård U, Rashid HU, Strand EK, Skjetne K, Seeberg KA, Torp R, Ystrøm CM, Vold C, Zettel CC, Waksvik K, Gulbrandsen B, Hagfors J, Mørk C, Jahnsen J, Kvien TK. Goll GL, et al. Among authors: kalstad s. J Intern Med. 2019 Jun;285(6):653-669. doi: 10.1111/joim.12880. Epub 2019 Apr 12. J Intern Med. 2019. PMID: 30762274 Free PMC article. Clinical Trial.
First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.
Lie E, Fagerli KM, Mikkelsen K, Rødevand E, Lexberg A, Kalstad S, Uhlig T, Kvien TK. Lie E, et al. Among authors: kalstad s. Ann Rheum Dis. 2014 Oct;73(10):1905-6. doi: 10.1136/annrheumdis-2014-205490. Epub 2014 Jul 2. Ann Rheum Dis. 2014. PMID: 24989896 No abstract available.
16 results